{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0052-0602",
      "generic_name": "BACILLUS CALMETTE-GUERIN",
      "labeler_name": "Merck Sharp & Dohme LLC",
      "brand_name": "TICE BCG",
      "active_ingredients": [
        {
          "name": "BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN",
          "strength": "50 mg/50mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0052-0602-02",
          "description": "1 VIAL in 1 CARTON (0052-0602-02)  / 50 mL in 1 VIAL (0052-0602-01)",
          "marketing_start_date": "19900824",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Merck Sharp & Dohme LLC"
        ],
        "rxcui": [
          "213744",
          "1653484"
        ],
        "spl_set_id": [
          "c9b74876-e665-442b-87ad-b7333bc9a67a"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0300520602020"
        ],
        "nui": [
          "N0000183904",
          "N0000183364",
          "M0022454",
          "M0002239",
          "N0000183906",
          "N0000183884",
          "N0000009357"
        ],
        "pharm_class_epc": [
          "Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]",
          "Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]"
        ],
        "pharm_class_pe": [
          "Actively Acquired Immunity [PE]",
          "Increased Macrophage Proliferation [PE]",
          "Increased Immunologically Active Molecule Activity [PE]"
        ],
        "pharm_class_cs": [
          "Vaccines, Attenuated [CS]",
          "BCG Vaccine [CS]"
        ],
        "unii": [
          "2XQ558L16Z"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "POWDER, FOR SUSPENSION",
      "spl_id": "223f2b2b-87d0-4beb-b00a-16a2b041a5bc",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INTRAVESICAL"
      ],
      "marketing_start_date": "19900824",
      "product_id": "0052-0602_223f2b2b-87d0-4beb-b00a-16a2b041a5bc",
      "application_number": "BLA102821",
      "brand_name_base": "TICE BCG",
      "pharm_class": [
        "Actively Acquired Immunity [PE]",
        "BCG Vaccine [CS]",
        "Increased Immunologically Active Molecule Activity [PE]",
        "Increased Macrophage Proliferation [PE]",
        "Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]",
        "Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]",
        "Vaccines",
        "Attenuated [CS]"
      ]
    }
  ]
}